Juva Life Inc. (JUVAF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Juva Life Inc. (JUVAF) trades at $0.00 with AI Score 56/100 (Grade B). Juva Life Inc. operates in the medical and recreational cannabis sectors, focusing on acquiring, owning, and operating cannabis businesses. Market cap: $1,641, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for JUVAF: JUVAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates JUVAF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
JUVAF: 2/6 perspectives are bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Juva Life Inc. (JUVAF) Healthcare & Pipeline Overview
Juva Life Inc., established in 2018, participates in the cannabis industry, focusing on both medical and recreational markets. With a negative profit margin of -181.9% and a low gross margin of 0.8%, the company faces significant challenges in profitability within a competitive landscape of specialty and generic drug manufacturers.
What Is the Investment Thesis for JUVAF?
Juva Life Inc. operates in the high-growth cannabis industry but faces significant financial challenges. Key value drivers include expanding its product portfolio and increasing market share in both medical and recreational cannabis sectors. The company's ability to improve its gross margin from the current 0.8% will be critical for achieving profitability. Upcoming catalysts include potential regulatory changes that could expand market access and new product launches targeting specific consumer segments. However, the company's negative profit margin of -181.9% and reliance on external funding pose substantial risks. The company's success hinges on effective execution of its growth strategy and navigating the complex regulatory landscape.
Based on FMP financials and quantitative analysis
JUVAF Key Highlights
- Market Cap of 2K indicates the company is a micro-cap stock with limited financial resources.
- P/E Ratio of -0.00 reflects the company's current lack of profitability.
- Profit Margin of -181.9% suggests significant operational inefficiencies and high costs.
- Gross Margin of 0.8% is extremely low, indicating challenges in product pricing and cost management.
- Beta of 0.62 suggests the stock is less volatile than the overall market.
Who Are JUVAF's Competitors?
JUVAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are JUVAF's Key Strengths?
- Vertically integrated operations.
- Focus on product innovation.
- Presence in both medical and recreational markets.
- Experienced management team.
What Are JUVAF's Weaknesses?
- Negative profit margin.
- Low gross margin.
- Limited financial resources.
- Reliance on external funding.
What Could Drive JUVAF Stock Higher?
- Potential regulatory changes that could expand market access.
- New product launches targeting specific consumer segments.
- Efforts to improve operational efficiency and reduce costs.
What Are the Key Risks for JUVAF?
- Financial-distress signal — its Altman Z-Score of -4.25 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-87.1%) — the business is not currently generating profit on shareholder capital.
- Intense competition in the cannabis industry.
- Regulatory uncertainties and varying state laws.
- Fluctuations in cannabis prices.
- Changes in consumer preferences.
- Negative profit margin and low gross margin.
What Are the Growth Opportunities for JUVAF?
- Expansion into New Markets: Juva Life can expand its geographic reach by entering new states or countries with favorable cannabis regulations. The global cannabis market is projected to reach $90.4 billion by 2026, offering significant growth potential. Successfully entering new markets could increase revenue and diversify the company's customer base. This expansion requires careful planning and compliance with local regulations, with a timeline of 2-3 years.
- Product Innovation and Development: Juva Life can invest in research and development to create innovative cannabis-based products and therapies. The market for cannabis-infused products is growing rapidly, with consumers seeking new and diverse options. Developing unique and high-quality products could attract new customers and increase brand loyalty. This involves ongoing investment and a timeline of continuous improvement.
- Strategic Acquisitions and Partnerships: Juva Life can pursue strategic acquisitions and partnerships to expand its capabilities and market reach. Acquiring complementary businesses or partnering with established players could provide access to new technologies, distribution channels, and customer segments. This strategy requires careful due diligence and integration, with a timeline of 1-2 years per transaction.
- Focus on Medical Cannabis: Juva Life can focus on the medical cannabis market, which offers higher margins and greater regulatory stability. Developing cannabis-based therapies for specific medical conditions could attract patients and healthcare providers. This requires clinical research and regulatory approvals, with a timeline of 3-5 years.
- Enhancing Operational Efficiency: Juva Life can improve its operational efficiency to reduce costs and increase profitability. This includes optimizing cultivation practices, streamlining manufacturing processes, and improving supply chain management. Reducing costs and improving margins are critical for long-term sustainability, with ongoing efforts to improve efficiency.
What Opportunities Does JUVAF Have?
- Expansion into new markets.
- Development of new cannabis-based therapies.
- Strategic acquisitions and partnerships.
- Increasing demand for cannabis products.
What Threats Does JUVAF Face?
- Intense competition.
- Regulatory uncertainties.
- Fluctuations in cannabis prices.
- Changes in consumer preferences.
What Are JUVAF's Competitive Advantages?
- Vertically integrated operations provide control over the supply chain.
- Focus on product innovation and quality.
- Established presence in key cannabis markets.
What Does JUVAF Do?
Juva Life Inc. was founded in 2018 and is headquartered in Vancouver, Canada. The company operates within the cannabis industry, focusing on acquiring, owning, and operating businesses in both the medical and recreational cannabis sectors. Juva Life aims to establish a vertically integrated business model, encompassing cultivation, processing, distribution, and retail operations. This approach allows the company to control the supply chain and ensure product quality from seed to sale. Juva Life's strategy involves identifying and acquiring promising cannabis businesses, implementing operational efficiencies, and expanding market reach. The company focuses on developing and offering a diverse range of cannabis products, including dried flower, concentrates, edibles, and topicals, catering to different consumer preferences and medical needs. Juva Life also invests in research and development to create innovative cannabis-based products and therapies. The company aims to differentiate itself through product quality, brand recognition, and customer experience. Despite its efforts, Juva Life faces challenges such as intense competition, regulatory uncertainties, and financial constraints. The company's negative profit margin of -181.9% and low gross margin of 0.8% indicate significant operational and financial hurdles. The company's success depends on its ability to navigate these challenges, execute its growth strategy, and achieve profitability in the rapidly evolving cannabis market.
What Products and Services Does JUVAF Offer?
- Acquires cannabis businesses in the medical and recreational sectors.
- Owns and operates cannabis cultivation facilities.
- Processes cannabis into various products, including dried flower, concentrates, and edibles.
- Distributes cannabis products to retail outlets.
- Operates retail cannabis stores.
- Conducts research and development to create new cannabis-based products and therapies.
How Does JUVAF Make Money?
- Generates revenue from the sale of cannabis products.
- Focuses on vertical integration to control the supply chain.
- Invests in research and development to create innovative products.
What Industry Does JUVAF Operate In?
Juva Life Inc. operates in the cannabis industry, which is experiencing rapid growth and evolving regulatory landscapes. The market is characterized by increasing demand for both medical and recreational cannabis products. However, the industry is also highly competitive, with numerous companies vying for market share. Juva Life faces competition from established players and new entrants, requiring the company to differentiate itself through product innovation, branding, and operational efficiency. Regulatory uncertainties and varying state laws add complexity to the business environment.
Who Are JUVAF's Key Customers?
- Medical cannabis patients seeking relief from various conditions.
- Recreational cannabis users seeking enjoyment and relaxation.
- Retail cannabis stores that purchase products for resale.
Company Profile
Juva Life Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Mathew Lee. JUVAF has traded publicly since 2021.
F-Score 4/9Financial Health
Juva Life Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -4.25 places it in the distress zone, a signal of elevated financial risk.
ROE -87%Key Financial Metrics
Return on equity for Juva Life Inc. stands at -87.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -51.5%, showing how much profit it generates from its asset base. A current ratio of 1.11 indicates the company holds enough short-term assets to cover its near-term obligations.
JUVAF Valuation & Market Position
With a 2K market cap, Juva Life Inc. sits in the micro-cap segment of the market. Relative to its peer group, JUVAF's quantitative score of 56/100 is below the peer average of 66/100.
JUVAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations.
- Focus on product innovation.
- Presence in both medical and recreational markets.
- Experienced management team.
Bear Case
- Negative profit margin.
- Low gross margin.
- Limited financial resources.
- Reliance on external funding.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
JUVAF Latest News
No recent news available for JUVAF.
JUVAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for JUVAF.
Price Targets
Wall Street price target analysis for JUVAF.
JUVAF MoonshotScore
What does this score mean?
The MoonshotScore rates JUVAF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Mathew Lee
CEO
Mathew Lee serves as the CEO of Juva Life Inc. His background includes experience in the cannabis industry, with a focus on business development and strategic planning. He has been involved in various aspects of the cannabis sector, including cultivation, processing, and retail operations. Lee's expertise lies in identifying growth opportunities and implementing strategies to expand market share.
Track Record: Under Mathew Lee's leadership, Juva Life Inc. has focused on acquiring and integrating cannabis businesses. Key milestones include expanding the company's product portfolio and establishing a presence in key cannabis markets. Lee has also overseen efforts to improve operational efficiency and reduce costs. However, the company continues to face financial challenges, as reflected in its negative profit margin.
JUVAF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Juva Life Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lower trading volume and liquidity.
- Higher price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Monitor news and developments related to the company.
- The company has been in operation since 2018.
- Juva Life Inc. operates in the cannabis industry.
- The company has a CEO and management team.
Common Questions About JUVAF (Healthcare)
What does Juva Life Inc. do?
Juva Life Inc. operates in the cannabis industry, focusing on acquiring, owning, and operating businesses in both the medical and recreational sectors. The company aims to establish a vertically integrated business model, encompassing cultivation, processing, distribution, and retail operations. Juva Life focuses on developing and offering a diverse range of cannabis products, including dried flower, concentrates, edibles, and topicals, catering to different consumer preferences and medical needs.
What do analysts say about JUVAF stock?
As of March 17, 2026, there is no available analyst coverage or consensus on Juva Life Inc. (JUVAF) due to its OTC listing and limited market capitalization. Investors should conduct their own thorough research and due diligence before considering an investment in JUVAF. Key valuation metrics such as price-to-earnings ratio and price-to-sales ratio are not meaningful due to the company's current lack of profitability and low revenue. Growth considerations include the company's ability to expand its market share and improve its financial performance.
What are the main risks for JUVAF?
Juva Life Inc. faces several significant risks, including intense competition in the cannabis industry, regulatory uncertainties, and fluctuations in cannabis prices. The company's negative profit margin and low gross margin indicate financial instability and operational inefficiencies. As an OTC-listed stock, JUVAF is subject to lower trading volume and liquidity, which can lead to price volatility. Investors should be aware of these risks and conduct thorough due diligence before investing in JUVAF.
What are the key factors to evaluate for JUVAF?
Juva Life Inc. (JUVAF) holds an AI score of 56/100 (moderate). Not financial advice.
How frequently does JUVAF data refresh on this page?
JUVAF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven JUVAF's recent stock price performance?
Juva Life Inc. (JUVAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider JUVAF overvalued or undervalued right now?
Valuing Juva Life Inc. (JUVAF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying JUVAF?
Before investing in Juva Life Inc. (JUVAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- Analyst coverage is non-existent due to the company's OTC listing.